Faculty Information - KURAMOCHI HIDEKAZU

（Last updated : 2024-04-15 15:24:22）

KURAMOCHI HIDEKAZU
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine

Position Associate Professor

■ Published papers

1.	Original article	Long-term Results of a Phase II Study of Neoadjuvant SOX for Advanced Gastric Cancer 2024/01
2.	Review article	Secondary Publication: Role of Molecular Targeted Drugs in Oncology 2023/12/20
3.	Original article	A Case of Pathologically Complete Response After Nivolumab Combined with Chemotherapy in a Gastric Cancer Patient with Virchow's Lymph Node Metastasis 2023/06
4.	Original article	Analysis of Circulating DNA to Assess Prognoses for Metastatic Colorectal Cancer Patients Treated with Regorafenib Dose-Escalation Therapy: A Retrospective, Exploratory Analysis of the RECC Trial. 2023/01/16
5.	Case report	Characteristic cerebrospinal fluid findings in immune checkpoint inhibitor-related peripheral neuropathy: A case report 2022/12/05
6.	Original article	Evaluation of Amphiregulin and Epiregulin mRNA Expressions as Prognostic Biomarkers for Patients with Stage III Colorectal Cancer 2022/01/07
7.	Original article	Phase II study of neoadjuvant chemotherapy with S-1 plus oxaliplatin for gastric cancer clinical T4 or N2-3. 2021/07
8.	Original article	Dramatic response of FOLFRINOX regimen in a collision pancreatic adenocarcinoma patient with a germline BRCA2 mutation: a case report 2019/12
9.	Original article	Amphiregulin/epiregulin mRNA Expression and Primary Tumor Location in Colorectal Cancer. 2019/09
10.	Original article	Influence of initial dose intensity on efficacy of FOLFIRINOX in patients with advanced pancreatic cancer. 2019/03/05
11.	Original article	Elevated levels of mRNAs encoding dihydropyrimidine dehydrogenase and thymidylate synthase are associated with improved survival of patients with hepatocellular carcinoma treated with S-1. 2017/07
12.	Original article	Phase II study of bevacizumab and irinotecan as second-line therapy for patients with metastatic colorectal cancer previously treated with fluoropyrimidines, oxaliplatin, and bevacizumab. 2017/03
13.	Original article	Early Tumor Shrinkage and Depth of Response as Predictors of Favorable Treatment Outcomes in Patients with Metastatic Colorectal Cancer Treated with FOLFOX Plus Cetuximab (JACCRO CC-05). 2016/06
14.	Original article	PTEN mRNA expression is less pronounced in left- than right-sided colon cancer: a retrospective observational study. 2016/01
15.	Original article	ERCC1 mRNA Expression as a Postperative Prognostic Marker in Extrahepatic Bile Duct Cancer 2014/12
16.	Original article	Degraded DNA may induce discordance of KRAS status between primary colorectal cancer and corresponding liver metastases 2014/02
17.	Original article	Enhancement of 5-fluorouracil-induced cytotoxicity by leucovorin in 5-fluorouracil-resistant gastric cancer cells with upregulated expression of thymidylate synthase. 2014/01
18.	Original article	Lymphatic vessel endothelial hyaluronan receptor-1 is a novel prognostic indicator for human hepatocellular caecinoma 2013
19.	Review article	Early Efficacy of Sorafenib Therapy in Advanced Hepatocellular Carcinoma 2012/04
20.	Original article	Amphiregulin and Epiregulin mRNA expression in primary colorectal cancer and corresponding liver metastases. 2012/03
21.	Original article	Comprehensive analysis of genetic polymorphisms and irinotecan-induced adverse events in Japanese gastrointestinal cancer patients:A DMET microarray profiling study. 2012
22.	Original article	Gene expression of the mismatch repair gene MSH2 in primary colorectal cancer. 2011/10
23.	Original article	Epidermal growth factor receptor (EGFR) mRNA levels and protein expression levels in primary colorectal cancer and corresponding liver metastases. 2010/05
24.	Case report	Drug monitoring during FOLFOX6 therapy in a rectal cancer patient on chronic hemodialysis. 2010/04
Display 5 items
Display all(24)

■ Academic conference presentation

1.	Experience of using Durvalumab + Gemcitabine + Cisplatin for advanced biliary tract cancer in our hospital 2024/02/22
2.	A study of dialysis patients treated with systemic chemotherapy at our hospital 2023/10/19
3.	Results of comprehensive genomic profiling tests for pancreaticobiliary cancer at our university’s hospital 2023/03/18
4.	Experience of using atezolizumab + bevacizumab for advanced hepatocellular carcinoma in our department 2022/10/20
5.	Chemotherapy for recurrent hepatocellular carcinoma after liver transplantation: A case report 2022/02/17
6.	No serious adverse events in a patient undergoing maintenance dialysis who was administered atezolizumab and bevacizumab for hepatocellular carcinoma: A case report 2020/10/20
7.	Efficacy and safety of oxaliplatin-based neoadjuvant chemotherapy for locally advanced rectal cancer patients 2019/10/25
8.	HER2 mRNA expression level is preserved in liver metastasis compared with corresponding primary colorectal cancer 2019/07/19
9.	Amphiregulin and Epiregulin mRNA expression in primary colorectal cancer and corresponding liver matastases 2011/07/21
10.	Amphiregulin and Epiregulin mRNA expression in primary colorectal cancer and corresponding liver metastases 2011/06
Display 5 items
Display all(10)

■ Education

1988/04～1994/03

School of Medicine, University of Tsukuba, Graduated